Valuation: DexCom, Inc.

Market Cap 29.46B 25.75B 23.8B 21.99B 41.41B 2,830B 42.16B 284B 111B 1,386B 111B 108B 4,771B P/E 2026 *
31.2x
P/E 2027 * 26.1x
Enterprise Value 29.06B 25.39B 23.47B 21.69B 40.84B 2,791B 41.58B 280B 110B 1,367B 109B 107B 4,706B EV / Sales 2026 *
5.56x
EV / Sales 2027 * 4.85x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-2.88%
1 week+0.65%
Current month+9.94%
1 month-0.24%
3 months+17.63%
6 months+6.23%
Current year+11.56%
1 week 71.25
Extreme 71.2532
76.42
1 month 67.3
Extreme 67.3
76.42
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
Jul. 05Sell

Chairman

-26,756 0.0069%
Jun. 14Sell

General Counsel

-1,700 0.0004%
Jun. 14Sell

Director

-4,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-2.94%+0.65%-13.23%-46.08% 29.46B
-2.76%-6.72%-32.29%-17.17% 160B
-4.77%-5.07%-11.31%-9.21% 107B
-1.30%-0.82%+1.66%+57.76% 59.56B
+0.35%-0.02%+43.33%+56.20% 52.51B
-2.06%-3.69%-15.00%-41.97% 42.39B
-3.52%-9.16% - - 34.31B
-0.29%+0.38%+59.22%-7.19% 25.41B
-3.26%-2.68%-7.17%-8.50% 21.15B
-0.42%+5.13%-3.90%-18.19% 21B
Average -2.08%+0.24%+2.37%-3.82% 55.32B
Weighted average by Cap. -2.49%-0.69%-7.27%-2.37%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.22B 3.9B 7.34B 502B 7.48B 50.34B 19.75B 246B 19.63B 19.19B 846B 5.83B 5.09B 4.71B 4.35B 8.19B 560B 8.34B 56.12B 22.02B 274B 21.88B 21.4B 943B
Net income 963M 841M 778M 718M 1.35B 92.46B 1.38B 9.27B 3.64B 45.27B 3.62B 3.54B 156B 1.16B 1.01B 935M 864M 1.63B 111B 1.66B 11.15B 4.38B 54.45B 4.35B 4.25B 187B
Net Debt -405M -354M -327M -302M -569M -38.91B -580M -3.9B -1.53B -19.05B -1.52B -1.49B -65.6B -1.21B -1.06B -979M -904M -1.7B -116B -1.73B -11.67B -4.58B -56.97B -4.55B -4.45B -196B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-07-14 $73.88 -3.24% 1,450,952
26-07-13 $76.35 +1.85% 3,553,999
26-07-10 $74.96 +2.66% 3,856,914
26-07-09 $73.02 -1.40% 4,163,972
26-07-08 $74.06 +0.67% 5,338,782
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
76.35USD
Average target price
85.24USD
Spread / Average Target
+11.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock